+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Ischemia Reperfusion Injury Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767606
  • Report
  • April 2019
  • Region: Global
  • 150 pages
  • VPA Research

FEATURED COMPANIES

  • Advocate Health Care
  • Arvid Nilsson Foundation
  • Dompe Farmaceutici SpA
  • F. Hoffmann-La Roche Ltd
  • Ischemix Inc
  • MallInckrodt Plc
  • MORE
The global clinical trial report- “2019 Ischemia Reperfusion Injury Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ischemia Reperfusion Injury. It presents in-depth analysis of Ischemia Reperfusion Injury clinical trials across markets and companies. The research work is for providing complete understanding into trends in Ischemia Reperfusion Injury.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Ischemia Reperfusion Injury clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Ischemia Reperfusion Injury

The research work is prepared through extensive and continuous research on Ischemia Reperfusion Injury trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Ischemia Reperfusion Injury patients are identified
  • The report includes panorama of Ischemia Reperfusion Injury clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Ischemia Reperfusion Injury clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Advocate Health Care
  • Arvid Nilsson Foundation
  • Dompe Farmaceutici SpA
  • F. Hoffmann-La Roche Ltd
  • Ischemix Inc
  • MallInckrodt Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Ischemia Reperfusion Injury Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Ischemia Reperfusion Injury Clinical Trials by Region
2.2.2 Average Enrollment of Ischemia Reperfusion Injury Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Ischemia Reperfusion Injury Treatment, 2019

3. Region wise Ischemia Reperfusion Injury Clinical Trials
3.1 Asia Pacific Ischemia Reperfusion Injury Clinical Trials by Country
3.2 Europe Ischemia Reperfusion Injury Clinical Trials by Country
3.3 North America Ischemia Reperfusion Injury Clinical Trials by Country
3.4 Middle East and Africa Ischemia Reperfusion Injury Clinical Trials by Country
3.5 South and Central America Ischemia Reperfusion Injury Clinical Trials by Country

4. Ischemia Reperfusion Injury Clinical Trial Trends
4.1 Start Year wise Ischemia Reperfusion Injury Clinical Trials
4.2 Phase wise Ischemia Reperfusion Injury Clinical Trials
4.3 Trial Status wise Ischemia Reperfusion Injury Clinical Trials
4.4 Trial Type wise Ischemia Reperfusion Injury Clinical Trials

5. Ischemia Reperfusion Injury Average Enrollment Trends
5.1 Average Enrollment in Ischemia Reperfusion Injury Trials by Year
5.2 Average Enrollment in Ischemia Reperfusion Injury Trials by Phase
5.3 Average Enrollment in Ischemia Reperfusion Injury Trials by Status
5.4 Average Enrollment in Ischemia Reperfusion Injury Trials by Type of Trial

6. Companies Participating in Ischemia Reperfusion Injury Clinical Trials
6.1 Ischemia Reperfusion Injury Trials by Sponsor Type
6.2 Ischemia Reperfusion Injury Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ischemia Reperfusion Injury Trials- Phase 1
7.2 Ischemia Reperfusion Injury Trials- Phase 2
7.3 Ischemia Reperfusion Injury Trials- Phase 3
7.4 Ischemia Reperfusion Injury Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Ischemia Reperfusion Injury Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Figure 7: North America - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Figure 9: Ischemia Reperfusion Injury Clinical Trials by Phase
Figure 10: Ischemia Reperfusion Injury Clinical Trials by Trial Status
Figure 11: Ischemia Reperfusion Injury Clinical Trials by Type
Figure 12: Ischemia Reperfusion Injury Clinical Trials by Sponsor Type
Figure 13: Ischemia Reperfusion Injury Clinical Trials by Leading Sponsors
Figure 14: Ischemia Reperfusion Injury Average Enrollment by Phase
Figure 15: Ischemia Reperfusion Injury Average Enrollment by Trial Status
Figure 16: Ischemia Reperfusion Injury Average Enrollment by Type
Figure 17: Ischemia Reperfusion Injury- Average Enrolment by Type of Sponsors
Figure 18: Ischemia Reperfusion Injury- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Ischemia Reperfusion Injury Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Table 5: Europe - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Table 7: North America - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ischemia Reperfusion Injury Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Ischemia Reperfusion Injury Average Enrollment by Phase
Table 15: Ischemia Reperfusion Injury Average Enrollment by Trial Status
Table 16: Ischemia Reperfusion Injury Average Enrollment by Type
Table 17: Ischemia Reperfusion Injury- Average Enrolment by Type of Sponsors
Table 18: Ischemia Reperfusion Injury- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • Advocate Health Care
  • Arvid Nilsson Foundation
  • Dompe Farmaceutici SpA
  • F. Hoffmann-La Roche Ltd
  • Ischemix Inc
  • MallInckrodt Plc
  • Minapharm Pharmaceuticals & Chemical Industries
  • Prolong Pharmaceuticals LLC
  • Stealth BioTherapeutics Inc
  • Y's Therapeutics Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll